90 related articles for article (PubMed ID: 8907317)
1. The in vitro effects of chylomicron remnant and very low density lipoprotein remnant on platelet aggregation in blood obtained from healthy persons.
Mochizuki M; Takada Y; Urano T; Nagai N; Nakano T; Nakajima K; Takada A
Thromb Res; 1996 Mar; 81(5):583-93. PubMed ID: 8907317
[TBL] [Abstract][Full Text] [Related]
2. Remnant-like lipoproteins stimulate whole blood platelet aggregation in vitro.
Knöfler R; Nakano T; Nakajima K; Takada Y; Takada A
Thromb Res; 1995 Apr; 78(2):161-71. PubMed ID: 7482433
[TBL] [Abstract][Full Text] [Related]
3. Aggregation of human blood platelets by remnant like lipoprotein particles of plasma chylomicrons and very low density lipoproteins.
Saniabadi AR; Umemura K; Shimoyama M; Adachi M; Nakano M; Nakashima M
Thromb Haemost; 1997 May; 77(5):996-1001. PubMed ID: 9184417
[TBL] [Abstract][Full Text] [Related]
4. Adenosine 5'-diphosphate as a factor in platelet aggregation induced by human plasma remnant lipoproteins.
Saniabadi AR; Umemura K; Suzuki Y; Kondo K; Ikeda Y; Adachi M; Nakashima M
Life Sci; 1998; 63(12):1065-74. PubMed ID: 9749829
[TBL] [Abstract][Full Text] [Related]
5. Effects of VLDL, chylomicrons, and chylomicron remnants on platelet aggregability.
Orth M; Luley C; Wieland H
Thromb Res; 1995 Aug; 79(3):297-305. PubMed ID: 8533125
[TBL] [Abstract][Full Text] [Related]
6. A novel role for CD36 in VLDL-enhanced platelet activation.
Englyst NA; Taube JM; Aitman TJ; Baglin TP; Byrne CD
Diabetes; 2003 May; 52(5):1248-55. PubMed ID: 12716760
[TBL] [Abstract][Full Text] [Related]
7. Effect of remnant-like particle on shear-induced platelet activation and its inhibition by antiplatelet agents.
Yamazaki M; Uchiyama S; Xiong Y; Nakano T; Nakamura T; Iwata M
Thromb Res; 2005; 115(3):211-8. PubMed ID: 15617744
[TBL] [Abstract][Full Text] [Related]
8. Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation.
Doi H; Kugiyama K; Ohgushi M; Sugiyama S; Matsumura T; Ohta Y; Nakano T; Nakajima K; Yasue H
Atherosclerosis; 1998 Apr; 137(2):341-9. PubMed ID: 9622277
[TBL] [Abstract][Full Text] [Related]
9. Recognition of chylomicron remnants and beta-migrating very-low-density lipoproteins by the remnant receptor of parenchymal liver cells is distinct from the liver alpha 2-macroglobulin-recognition site.
van Dijk MC; Ziere GJ; Boers W; Linthorst C; Bijsterbosch MK; van Berkel TJ
Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):863-70. PubMed ID: 1719960
[TBL] [Abstract][Full Text] [Related]
10. Plasma very low density lipoprotein (VLDL) in cholesterol-fed rabbits: chylomicron remnants or liver lipoproteins?
Thompson KH; Zilversmit DB
J Nutr; 1983 Oct; 113(10):2002-10. PubMed ID: 6619979
[TBL] [Abstract][Full Text] [Related]
11. Daily variation of serum lipids in relation to the circadian rhythm of platelet aggregation in healthy male persons.
Knöfler R; Urano T; Taminato T; Yoshimi T; Nakano T; Nakajima K; Takada Y; Takada A
Clin Chim Acta; 1995 Aug; 239(2):109-19. PubMed ID: 8542649
[TBL] [Abstract][Full Text] [Related]
12. Comparison of binding and removal of remnants of triglyceride-rich lipoproteins of intestinal and hepatic origin by rat liver in vitro.
Cooper AD; Shrewsbury MA; Erickson SK
Am J Physiol; 1982 Nov; 243(5):G389-95. PubMed ID: 7137355
[TBL] [Abstract][Full Text] [Related]
13. Removal of triacylglycerols from chylomicrons and VLDL by capillary beds: the basis of lipoprotein remnant formation.
Karpe F; Bickerton AS; Hodson L; Fielding BA; Tan GD; Frayn KN
Biochem Soc Trans; 2007 Jun; 35(Pt 3):472-6. PubMed ID: 17511631
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels.
Nakajima K; Saito T; Tamura A; Suzuki M; Nakano T; Adachi M; Tanaka A; Tada N; Nakamura H; Campos E
Clin Chim Acta; 1993 Dec; 223(1-2):53-71. PubMed ID: 8143370
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity.
Chan DC; Watts GF; Mori TA; Barrett PH; Redgrave TG; Beilin LJ
Am J Clin Nutr; 2003 Feb; 77(2):300-7. PubMed ID: 12540386
[TBL] [Abstract][Full Text] [Related]
16. Atherogenic postprandial remnant lipoproteins; VLDL remnants as a causal factor in atherosclerosis.
Nakajima K; Tanaka A
Clin Chim Acta; 2018 Mar; 478():200-215. PubMed ID: 29307667
[TBL] [Abstract][Full Text] [Related]
17. Interrelationship of triglycerides with lipoproteins and high-density lipoproteins.
Gotto AM
Am J Cardiol; 1990 Sep; 66(6):20A-23A. PubMed ID: 2203246
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E enrichment of immuno-separated chylomicron and chylomicron remnants following saturated fatty acids.
Jackson KG; Wolstencroft EJ; Bateman PA; Yaqoob P; Williams CM
Nutr Metab Cardiovasc Dis; 2006 Sep; 16(6):405-17. PubMed ID: 16935699
[TBL] [Abstract][Full Text] [Related]
19. [Effects of plasma very low density lipoprotein, low density lipoprotein and high density lipoprotein on platelet aggregation in endogenous hypertriglyceridemia].
Deng Z; Liu B; Zhou J; Zhang Z; Liu Y; Bai H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 34(4):704-7. PubMed ID: 14619587
[TBL] [Abstract][Full Text] [Related]
20. The kinetic parameters of the uptake of very-low-density lipoprotein remnant cholesteryl esters by perfused rat livers.
Noël SP; Dupras R
Biochim Biophys Acta; 1983 Nov; 754(2):117-25. PubMed ID: 6580919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
